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The MRN complex (Mre11/Rad50/Nbs1) is important
in double-strand break (DSB) recognition, end resec-
tion, replication fork stabilization, and ATM and ATR
activation. Complete deletion of MRN is incom-
patible with cell and organism life, presumably
due to replication-born DSBs; however, the under-
lying mechanism remains unknown. We devised
a noninvasive high-content assay, termed high-
contentmicroscopy-assisted cell-cycle phenotyping
(hiMAC), to investigate the fate of cells lacking Nbs1.
Surprisingly, deletion of Nbs1 does not kill cells dur-
ing replication. The primary lesions in Nbs1-deleted
cells are replication intermediates that result from
defective resolution rather than fork destabilization.
These lesions are converted to DSBs in the subse-
quent G2 phase, which subsequently activate Chk1,
delayG2progression, and lead tochromosome insta-
bility. Nbs1-deleted cells establish a DSB equilibrium
that permits cell cyclingbut activatesp53, causingG1
and G2 arrest, and cell death. Thus, we identify a
physiological role of Nbs1 in the resolution of stalled
replication forks.INTRODUCTION
The integrity of genomic DNA is essential for the life of all organ-
isms. Two major DNA damage response (DDR) signaling
cascades, the ATM and ATR pathways, are activated by DNA
double-strand breaks (DSBs) and single-stranded DNA (ssDNA),
respectively, to coordinate the repair of damage and to eliminate
cells with unrepairable damage (Ciccia and Elledge, 2010). The
classic view of the early DDR cascade is that the MRN complex,
consisting of Mre11, Rad50, and Nbs1, functions to preferen-
tially activate ATM in response to DSBs, and ATR is activated
by RPA-ssDNA and TopBP1 in response to DNA single-strand
breaks (SSBs) and stalled replication forks (Cimprich andCortez,182 Cell Reports 6, 182–195, January 16, 2014 ª2014 The Authors2008; Flynn and Zou, 2011; Shiloh and Ziv, 2013; Stracker and
Petrini, 2011).
The MRN complex is a major sensor of DSBs. It binds to and
stabilizes broken DNA ends, and promotes the activation of
ATM to elicit Chk2-mediated cell-cycle checkpoints and DSB
repair via homologous recombination (HR) and nonhomologous
end joining (NHEJ) (Shiloh and Ziv, 2013; Stracker and Petrini,
2011). Recent studies have revealed an important function of
MRN in the activation of the ATR pathway and the subsequent
phosphorylation of Chk1 upon DSBs and replication stress. In
S (DNA replication) andG2 phases, theMRNcomplex processes
DSB ends into ssDNA along with CtIP, Dna2, Exo1, and Sgs1 to
facilitate ATR activation, and is also thought to promote the
repair of DSBs through the HR pathway (Cejka et al., 2010;
Sartori et al., 2007; Zhu et al., 2008). Moreover, MRN (or Nbs1)
seems to have a direct regulatory role in the activation of ATR
and Chk1 in the replication checkpoint (Duursma et al., 2013;
Lee and Dunphy, 2013; Shiotani et al., 2013; Willis and Rhind,
2010). Thus, MRN participates in the activation of ATM and
ATR differently depending on the cell-cycle phase and, more
importantly, on the physiological condition in vivo. Although
ATM is dispensable for mammalian development, all compo-
nents of the MRN complex are essential for the viability of
mammalian cells (Dumon-Jones et al., 2003; Luo et al., 1999;
Xiao and Weaver, 1997; Zhu et al., 2001). Of note, inactivation
of the ATR-Chk1 pathway also leads to early embryonic lethality
in mice (Brown and Baltimore, 2000; Liu et al., 2000), which is
believed to be caused by replication-born DSBs (Casper et al.,
2002; Toledo et al., 2011).
Many DDR genes are essential for embryonic development
and cell survival even in the absence of obvious exogenous
damage. About 10,000–40,000 SSBs and about 50 DSBs are
produced endogenously per cell daily (Vilenchik and Knudson,
2003), and a single unrepaired DSB is able to kill a cell (Goodsell,
2005). Because essential DDR genes are often involved in DSB
prevention or repair, it is believed that endogenous DSBs drive
the death of DDR-deficient cells; however, this remains specula-
tive at this point. Although exogenous DNA damage treatments,
such as genotoxic agents and UV and ionizing radiation, have
generated valuable information about the function of these
essential DDR genes in the handling of acute exogenous
damages and cell death (Lord and Ashworth, 2012), such exper-
imental approaches may mask their physiological functions in
the unperturbed cellular condition. The current view implies
that in the absence of either MRN or ATR, the collapse of the
replication fork similarly induces DSBs, and these DSBs kill
MRN-null and ATR-null cells. However, the origin of the primary
endogenous damage, and how these lesions eventually cause
cell death in MRN- and ATR-null cells under physiological
conditions have not been formally demonstrated. In the present
study, we developed a high-content microscopy approach
to assemble ‘‘cell-cycle-based DNA-damage fingerprints’’ in
an asynchronous cell population. Using this approach, we
generated a comprehensive picture of the cellular events caused
by deletion of Nbs1.
RESULTS
Nbs1 Deletion Does Not Induce Acute Cell Lethality
Cell life is not compatible with complete deletion of any compo-
nent of the MRN complex. Therefore, to study the fate of MRN-
deficient cells, we used inducible Nbs1-null mouse embryonic
fibroblasts (MEFs; Nbs1F/F;CreER [hereafter denoted CER])
(Yang et al., 2006) as amodel system (Figure S1A). Western blot-
ting showed that the Nbs1 protein was efficiently deleted as early
as 3 days after 4-OHT treatment (3 dpo) and was completely ab-
sent at 5 dpo (Figures S1B and S1C; data not shown), and thus
we designated these cells as Nbs1 deleted (Nbs1-del). Deletion
of Nbs1 caused dislocation of Mre11 and Rad50 from chromatin
to cytoplasm (Figure 1A), indicating a disruption of the MRN
complex as shown in human NBS cells (Carney et al., 1998).
We monitored proliferation and apoptosis in Nbs1-del cells by
incorporation of 5-ethynyl-20-deoxyuridine (EdU) and flow
cytometry of Annexin V, respectively. Surprisingly, cells under-
went proliferation arrest only at 9 dpo (Figure 1B) and increased
apoptosis was not detectable before 12 dpo (Figure 1C).
Concurrently with the loss of the Nbs1 protein, we observed
the formation of gH2AX foci as early as 4 dpo (see below) and
6 dpo (Figure 1D), which marks DNA lesions (Meek, 2009). Reex-
pression ofNbs1 cDNA rescued the phenotype ofNbs1-del cells
in DNA damage, proliferation arrest, and apoptosis (Figures 1B–
1D and S1D), ruling out the side effect of Cre recombinase in this
experimental setting. Altogether, these results indicate that dele-
tion of Nbs1 does not cause immediate cell death, but triggers
sequential phenotypic changes with an initial phase of DNA
damage, followed by a second phase of proliferation arrest
and finally a third phase of cell death (Figure 1E).
Establishment of the hiMAC Method
Wewanted to investigate the source of DNAdamage inNbs1-del
cells and its impact on cell fate. The dynamic nature of DNAdam-
age throughout an unperturbed cell cycle poses a technical
challenge to the identification of the origin and fate of DNA
lesions. To overcome this limitation, we developed a noninva-
sive, quantitative, and unbiased method to characterize DNA
damage together with cell-cycle parameters in asynchronous
cell populations, thereby avoiding unphysiological disturbance.
We termed this approach high-content microscopy-assisted
cell-cycle phenotyping (hiMAC) because it allows the assemblyCof comprehensive ‘‘cell-cycle-based DNA-damage fingerprints’’
(Figure S2). The hiMAC procedure starts with pulse labeling of
cells with EdU, followed by click reaction to conjugate Alexa
Fluor 647 fluorophore to EdU. Proteins of interest and DNA are
stained by immunocytochemistry and DAPI, respectively (Fig-
ure S2A), and images are acquired by automated confocal
microscopy (Figure S2B). A customized image analysis pipeline
(Cell Profiler software) (Kamentsky et al., 2011) is used to mea-
sure the intensities of DAPI (DNA content and DNA condensa-
tion) and EdU-Alexa Fluor 647 (replication status) in individual
nuclei to derive the cell-cycle status (e.g., G1, early/mid/late S,
early G2, and late G2/M). Simultaneously, the pattern of objects
of interest, such as proteins, subcellular organelles, and micro-
nuclei (MN), can be visualized and analyzed by high-content
fluorescence microscopy (Figures S2B–S2E). Thus, hiMAC links
subcellular structural information to cell-cycle status aswell as to
dynamic protein localization, modification, and interactions.
Accumulation of Replication Intermediates in Nbs1-del
Cells
First, we applied hiMAC analysis to trace the origin of DNA
damage in Nbs1-del cells by monitoring gH2AX foci in individual
cell-cycle phases early after Nbs1 deletion. We found that
gH2AX foci first appeared at 4 dpo, but mainly in S and G2
phases (Figures 1F and 1G). Similar results were obtained using
small interfering RNA (siRNA) knockdown of Nbs1 (Figures S3A
and S3B). These data suggest that replication forks were prob-
ably the source of the first DNA damage. Consistent with this
notion, we found that RPA foci, which mark tracts of ssDNA in
stalled replication forks, were significantly higher in Nbs1-del
cells in S phase compared with control cells (Figures 1H and
1I). Although RPA foci declined when control cells entered G2
phase, they persisted in G2 Nbs1-del cells (Figures 1H and 1I).
Strikingly, colocalization of RPA and 53BP1 foci, which mark
DSBs and form independently from the MRN complex (Lukas
et al., 2011b), was low in S phase (2%) but increased in G2 phase
(14%) in Nbs1-del cells (Figure 1I). Finally, as ATM/DNA-PK and
ATR differentially phosphorylate H2AX at replication intermedi-
ates and DSBs, respectively, we used inhibitors of these kinases
to further analyze the nature of spontaneous gH2AX foci inNbs1-
del cells, and found that ATR inhibition, but not combined inhibi-
tion of ATM and DNA-PK, reduced the number of gH2AX foci in
Nbs1-del G2 cells (Figure S4), suggesting they likely mark
ssDNA. Altogether, these data suggest that the gH2AX foci
and RPA foci in S phase Nbs1-del cells represent replication
intermediates, but not DSBs. This differs from previous findings
in Xenopus egg extract, which showed that Mre11 deletion
resulted in DSB formation during S phase (Costanzo et al., 2001).
We next investigated the sources of replication intermediates.
Consistent with a function during replication (Lopez-Contreras
et al., 2013), the formation of Nbs1 foci during an unperturbed
S phase was specifically enriched in late S phase (Figures 2A
and 2B). To further test whether the intermediates would inter-
fere with replication, we assessed the continuity of replication
fork progression in Nbs1-del cells using the fiber assay. We
labeled sequentially nascent DNA with chlorodeoxyuridine
(CldU; first label) and iododeoxyuridine (IdU; second label) under
unperturbed conditions (Figure 2C). Whereas fibers from controlell Reports 6, 182–195, January 16, 2014 ª2014 The Authors 183
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Figure 1. Nbs1 Deletion Induces Accumulation of Replication Intermediates, but Not Cell Lethality
(A) Western blot analysis of MRN components in subcellular fractions of Nbs1-inducible null (Nbs1F/F; CreERT2+) and control (Nbs1F/+; CreERT2+) cell lines.
b-Tubulin and histone H3 were used as loading controls for cytoplasmic (S1) and insoluble nuclear (P2) fractions, respectively.
(B) High-content microscopy analysis of 24 hr EdU incorporation in CER, Nbs1 reconstituted CER (CER + Nbs1), and EV MEF cells at the indicated dpo (n = 3).
***p < 0.001 as compared with no 4-OHT treatment ( 4-OHT; one-way ANOVA with Tukey’s test).
(C) Flow-cytometry analysis of apoptosis (DAPI/Annexin V) in CER, CER + Nbs1, and EV cells at the indicated dpo. Treatment with 1 mMMNNG for 30 min, 24 hr
before analysis, was used as positive control (n = 3). **p < 0.01 as compared with  4-OHT (one-way ANOVA with Tukey’s test).
(D) High-contentmicroscopy analysis of gH2AX foci in CER, CER +Nbs1, and EV cells at the indicated dpo (n > 200 cells). ***p < 0.001 as comparedwith 4-OHT
(Kruskal-Wallis test with Dunn’s test).
(E) Schematic summary of (B)–(D).
(F) Representative images of Nbs1-del cells of the indicated cell-cycle phases at 4 dpo stained with gH2AX antibody, EdU, and DAPI. Bars, 3 mm.
(G) hiMAC quantification of gH2AX foci per nucleus in Nbs1-del (4 dpo) and control cells. At least 140 cells were analyzed for each cell-cycle phase. ***p < 0.001
(Mann-Whitney test).
(H) Representative images of Nbs1-del (6 dpo) and control G2 cells stained with RPA and 53BP1 antibodies and DAPI. Bars, 3 mm.
(legend continued on next page)
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cells exhibited similar lengths of IdU and CldU stretches, Nbs1
deletion increased the frequency of fibers with shorter IdU labels
(Figures 2C–2E). Consistent with this observation, analysis of
IdU-labeled fibers at the replication origins revealed that Nbs1
deletion resulted in an increased origin asymmetry (Figures 2F
and 2G). These findings suggest that replication forks are the
damaged sites.
Nbs1 Is Required for the Resolution of Replication
Intermediates
The accumulation of replication intermediates can be a conse-
quence of either replication fork destabilization (Lukas et al.,
2011a) or impaired resolution of replication intermediates (Su
et al., 2008). To distinguish between these two possibilities, we
enforced either replication fork destabilization with a low dose
of the DNA polymerase inhibitor Aphidicolin (APH, 200 nM) that
did not block S phase progression (Figure S5), or replication
fork blockage by the interstrand crosslink (ICL) inducer mito-
mycin C (MMC). hiMAC analysis revealed that Nbs1 deletion
had aminor effect on gH2AX focus formation in S andG2 phases
after APH (Figures 3A and 3B). However, MMC induced more
gH2AX foci in G2 phase of Nbs1-del cells compared with control
cells despite the similar amount of gH2AX foci in S phase
(Figures 3C and 3D). Consistently, Nbs1-del cells showed pro-
nounced hypersensitivity toward MMC, but not APH, in a cyto-
toxicity assay (Figure 3E). These data indicate that Nbs1 is
dispensable for the stability of stalled replication forks, but is
important for the resolution of blocked replication forks.
Wenext investigated the role of theHRpathway in the accumu-
lationof replication intermediatesbymonitoringRad51, and found
thatNbs1-del cells containedmoreRad51 foci inSandG2phases
thancontrol cells (Figures3F and3G). TheseRad51 foci appeared
in S phase and almost completely colocalized with RPA in G2
phase (Figures 3F and 3G), suggesting that Rad51 foci may
mark these replication intermediates as HR substrates. We next
asked whether inefficient HR in Nbs1-del cells was the cause of
the intermediate accumulation (Figure 3H). hiMAC analysis of
Nbs1-del and control cells after transfection of GFP-tagged
shRad51 revealed that Rad51 knockdown resulted in increased
gH2AX foci in S and G2 phase, similar to Nbs1 deletion alone
(Figures 3I and 3J). Strikingly, combined deletion of Nbs1 and
knockdown of Rad51 caused the same increase in gH2AX foci
as did knockdown ofRad51 alone (Figures 3I and 3J), suggesting
that Nbs1 and Rad51 operate in the same pathway, as expected
(Stracker and Petrini, 2011). It also suggests that the Rad51
foci seen in Nbs1-del cells represent HR substrates (replication
intermediates) rather than an indicator of the HR activity. Alto-
gether, these results indicate that replication intermediates
accumulate in Nbs1-del cells due to deficient resolution via HR.
DNA Damage Progression in Subsequent Cell Cycles
We next followed the fate of replication intermediates during G2
phase and measured kinetic changes in gH2AX and 53BP1 foci(I) hiMAC quantification of RPA foci per nucleus noncolocalizing (white bars) or c
Colocalization of RPA foci to 53BP1 foci and the total number of analyzed cells (
comparison of total RPA foci (*) or RPA/53BP1 double-positive foci (#) (Kruskal-W
The error bars represent the SEM. See also Figures S1–S4.
Cin G2 cells, which were EdU negative with 4NDNA during contin-
uous EdU labeling (Figures 4A–4C). We found that the amount of
53BP1 foci, but not gH2AX foci, increased in G2 cells during 5 hr
of EdU labeling (Figures 4B and 4C), indicating the conversion of
replication intermediates to DSBs in G2 phase. Further, we
followed DNA damage progression through mitosis and found
that DSBs in Nbs1-del cells progressed to anaphase DNA
bridges and chromatid breaks (Figures 4D and 4E). Upon exiting
from mitosis to G1 phase, Nbs1-del cells with persistent gH2AX
foci acquired MN (Figures 4F, S6A, and S6B), which accumu-
lated further DNA damage during the next DNA replication (Fig-
ures S6C–S6E). We also monitored the progression of DNA
damage in the main nucleus of Nbs1-del cells during 5 dpo
and 6 dpo, which correspond to the first and second cycles
after primary damage induction, respectively (see Figures 1F
and 1G). hiMAC revealed that Nbs1-del cells entered the next
G1 phase (5 dpo) with increased DSBs, as judged by the coloc-
alization of gH2AX and 53BP1 foci (Figures 4G, 4H, and S6F).
Furthermore, replication intermediates (gH2AX foci) emerged in
the subsequent S phase and accumulated in G2 phase (5 dpo)
(Figure 4H). Interestingly, the number of 53BP1 foci in Nbs1-
del cells was unchanged between cell cycles throughout 5 dpo
and 6 dpo, although there was a slight increase of gH2AX foci
(Figures 4H and 5; dpo versus 6 dpo). Thus, in spite of continu-
ously generated replication intermediates during cell-cycle pro-
gression, Nbs1-del cells eventually maintained at a steady state
of DSBs.
Nbs1 Deletion Elicits Progressive Proliferation Arrest
Prior to Apoptosis
We next investigated the fate of Nbs1-del cells carrying DNA
damage, and assessed cell-cycle phase durations using the
cumulative EdU labeling assay (Gruber et al., 2011; Nowakowski
et al., 1989). Nbs1 deletion (9 dpo) lengthened specifically G1
and G2 phases (Figures 5A, S7A, and S7B), and hiMAC analysis
revealed that cells accumulated in G0/G1 (EdU, 2N) and G2
(EdU, 4N) cells during 24 hr of EdU labeling (Figures 5B and
5C), indicating proliferation arrest in G1 and G2. Next, we
performed live-cell imaging after transfection with the FUCCI
reporter system in Nbs1-del cells at 10–12 dpo, which allows
the distinction of G1 and S/G2 phases (Sakaue-Sawano et al.,
2008). Nbs1-del cells exhibited an enhanced G1 and S/G2 arrest
(Figure S7C). Interestingly, after extended arrest, cell death
occurred mainly in S/G2 phase, but less frequently in G1 and
M phases (Figures 5D and 5E). Thus, stable cell-cycle arrest in
G1 and G2 is the major outcome of Nbs1 deletion, which finally
leads to cell death in G2.
Replication Intermediates Drive a Chk1-Dependent G2
Delay in Nbs1-del Cells
We next interrogated the mechanism underlying distinct cell-
cycle arrests in Nbs1-del cells. Strikingly, we found that the
increased G2 population of Nbs1-del cells readily coincidedolocalizing (black bars) with 53BP1 foci in Nbs1-del (6 dpo) and control cells.
N) are indicated. ns, not significant; */#p < 0.05; **/##p < 0.01; ***p < 0.001 for
allis test with Dunn’s test).
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Figure 2. Nbs1 Deletion Affects Continuity of Replication
(A) Representative images of CER control cells of the indicated cell-cycle phases pulse labeled with EdU and stained with Nbs1 and gH2AX antibodies, EdU, and
DAPI. Bars, 4 mm.
(B) hiMAC quantification of spontaneous Nbs1 foci per nucleus inNbs1-del (5 dpo) and control cells from (A) from at least 50 cells per cell-cycle phase. *p < 0.05;
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(C) Representative images of DNA fibers prepared from Nbs1-del (5 dpo) and control cells after sequential 25 min pulse labeling with CldU (red) and IdU (green).
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(D) Distribution of IdU/CldU length ratios from at least 400 individual fibers from Nbs1-del (5 dpo) and control cells from three independent experiments.
(E) Quantification of fibers with IdU/CldU length ratio smaller than 0.75 corresponding to the colored areas in the fiber length ratio distribution in (D) (n = 3
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(F) Representative images of DNA fibers representing replication origins prepared as in (C). Bars, 2 mm.
(G) Quantification of origin asymmetry from at least 100 origins from three independent experiments. Asymmetry was calculated as the ratio of long versus short
IdU stretch in the same fiber. *p < 0.05 (Student’s t test).
The error bars represent the SEM.with the initial appearance of replication intermediates (4 dpo;
data not shown). MMC-enforced replication intermediate forma-
tion augmented G2 accumulation specifically in Nbs1-del cells
(Figure 6A). Similarly, inhibition of poly(ADP-ribosyl)ation, which
participates in the resolution of replication intermediates (Peter-
mann and Helleday, 2010), also enhanced G2 accumulation in
Nbs1-del cells, as well as replication fork collapse (53BP1 foci)186 Cell Reports 6, 182–195, January 16, 2014 ª2014 The Authorsand cell death (Figures 6A–6C). These results indicate that unre-
solved replication intermediates were likely the reason for G2
phase prolongation.
We next analyzed the DDR pathway that was responsible for
the delayed G2 progression. The transition through G2 phase
is controlled by Cdk1 kinase activity, which is regulated by the
Chk1-Cdc25 axis and by Wee1 (Chen et al., 2012). We found
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after 24 hr recovery (C andD). Values represent absolute numbers of gH2AX foci (A andC) or differences of gH2AX foci induced by respective treatments (B andD)
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Quantification of cells was performed by high-content microscopy analysis of DAPI-stained nuclei (n = 5). **p < 0.01; ***p < 0.001 (Student’s t test).
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3 days after shRNA transfection. Dhx9 was used as loading control.
(legend continued on next page)
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an induction of Chk1 phosphorylation in Nbs1-del cells and a
concurrent hyperphosphorylation of Cdk1 (Y15) (Figure 6D).
Chemical inhibition of either Chk1 or Wee1 accelerated G2
phase transition (Figures 6E and 6F) and reduced the G2 fraction
of Nbs1-del cells (Figure S7D). Thus, the G2 delay in Nbs1-del
cells likely occurs via a Cdk1-dependent mechanism.
p53-Dependent Proliferation Arrest in Nbs1-del Cells
Restricts DNA Damage, Nuclear Fragmentation, and
Cell Death
We next asked whether stable G0/G1 arrest of Nbs1-del cells
was driven by persistent DNA damage and genomic instability.
We applied hiMAC analysis to assess the correlation among pro-
liferative capacity, gH2AX foci, and MN. Indeed, cells with more
gH2AX foci or MN were less proliferative, as judged by Ki67
staining (Figures 7A–7C), indicating that both persistent nuclear
DNAdamage andMNcontribute to proliferation arrest. We found
a hyperphosphorylation of p53 and concurrent p21 upregulation
in Nbs1-del cells (Figure 7D). To ultimately confirm that p53 acti-
vation is responsible for proliferation arrest and apoptosis in
Nbs1-del cells, we established Nbs1-inducible null MEFs in a
p53-null background (Figure 7E). Strikingly, p53 deficiency
completely restored proliferation of Nbs1-del MEFs at 10 dpo
(Figures 7F and 7G). Intriguingly, these rescued cells exhibited
massive gH2AX foci (Figures 7H and 7I), nuclear fragmentation
(Figure 7J), and apoptosis (Figures 7K and 7L). These results
strongly argue that p53 activation represents a key antiprolifera-
tive, rather than proapoptotic, mechanism in Nbs1-del cells.
DISCUSSION
TheMRN complex, like ATR, is essential for mammalian cell pro-
liferation and survival (Dumon-Jones et al., 2003; Luo et al.,
1999; Xiao and Weaver, 1997; Zhu et al., 2001). The discovery
of an ATR-dependent role of MRE11 in collapsed replication
forks (Trenz et al., 2006) may explain the lethality of MRN
mutants. In addition, a structural function of MRN by tethering
sister chromatids has been suggested to prevent replication-
induced DSBs (Tittel-Elmer et al., 2009). Finally, the fact that
the MRN complex is required to activate ATR-Chk1 in response
to stalled replication forks (Duursma et al., 2013; Lee and Dun-
phy, 2013; Shiotani et al., 2013) places MRN upstream of the
ATR pathway. Therefore, DSBs as the primary lesions generated
in replication are thought to be the driving force of lethality in
MRN-deficient cells.
In this study, the hiMAC assay allowed us to investigate the
initiation and progression of DNA damage, and, ultimately, the
cell fate of Nbs1-deficient cells in a physiological setting.
Surprisingly, the DNA lesions generated in Nbs1-del cells were
not DSBs but replication intermediates. This was indicated by
several lines of evidence. First, we observed RPA foci that did
not overlap with DSB marker 53BP1 (Figure 1I), and epistasis(I) Representative images ofNbs1-del (4 dpo) and control G2 cells transfected with
fixed 3 days after shRNA transfection and stained with gH2AX and GFP antibod
(J) hiMAC quantification of gH2AX foci per nucleus in GFP-positive cells from (I) (
test).
The error bars represent the SEM. See also Figure S5.
188 Cell Reports 6, 182–195, January 16, 2014 ª2014 The Authorsof Nbs1 and Rad51 in gH2AX focus formation (Figure 3J). Sec-
ond, the fiber assay revealed a stochastic interruption of replica-
tion (Figures 2C–2G), suggesting, together with MMC treatment
data, an intermediate accumulation. Finally, only ATR inhibitor,
and not ATM/DNA-PK inhibitors, reducedgH2AX foci (Figure S4),
indicating their ssDNA nature. We show that unresolved replica-
tion intermediates in Nbs1-del cells resulted in a prolonged G2
phase mediated by Chk1 activation. The overactivation of
Chk1 in Nbs1-del cells might be surprising given that the MRN
complex is important in ATR-Chk1 activation in biochemical
tests and also in cells after ionizing radiation or laser damage
(Jazayeri et al., 2006; Sartori et al., 2007). However, in vivo
studies demonstrated that ATR activation was not compromised
in the absence of Nbs1 in lymphoid organs (Difilippantonio et al.,
2005) and neural tissues (Zhou et al., 2012). Moreover, we found
that gH2AX foci in S and G2 phases ofNbs1-del cells are depen-
dent onATR activity, but not ATM/DNA-PKpathways (Figure S4).
Thus, replication intermediates can be a bona fide stimulus for
ATR/Chk1 activation without involving MRN.
Our findings show that the essential function of the MRN com-
plex is the resolution of replication intermediates, rather than the
repair of replication-born DSBs. Several possibilities have been
proposed for the function of the MRN complex in the restoration
or repair of replication fork damages. Mre11 can promote the
restart of replication forks blocked by either MMC or campto-
thecin (topoisomerase I inhibitor), but not replication forks stalled
by APH (a reversible DNA polymerase inhibitor) (Trenz et al.,
2006). Another study reported that Mre11 depletion delayed
the restart of HU-stalled replication forks, likely due to inefficient
resection, which is necessary for promoting HR (Bryant et al.,
2009). Our data on DNA damage accumulation and cell survival
in the presence of MMC and APH (Figures 3A–3E) permit us to
conclude that the MRN complex prevents intermediate accumu-
lation by resolving physical replication blocks, and not by restart-
ing transiently stalled forks.
Because Nbs1-del cells passed through S phase in a normal
kinetics and arrested in G2 after MMC treatment, it is unlikely
that the intra-S phase checkpoint function would be responsible
for the intermediate resolution defect. Rather, Nbs1 facilitates
the intermediate resolution by promoting HR before replication
forks collapse. This is consistent with the role of MRN as HR
initiator (Yang et al., 2006) and an epistatic relation of Rad51
and Nbs1 in the prevention of replication intermediates (Fig-
ure 3J). Consistently, depletion of Rad51 in DT40 cells causes
the accumulation of replication intermediates and consequent
G2 arrest (Su et al., 2008). Moreover, the sensitivity of Nbs1-
del cells to PARP inhibitor is reminiscent of HR mutants (Bans-
bach and Cortez, 2011), arguing that the function of Nbs1 in
intermediate resolution is HR. Therefore, the MRN complex
and HR operate in the same pathway to resolve replication inter-
mediates to prevent DSB formation in the subsequent G2 phase.
Strikingly, Nbs1-del cells can tolerate replication intermediatesGFP-tagged shRNA vectors targeting Rad51 or Luciferase (shLuc). Cells were
ies, EdU, and DAPI. Bars, 3 mm.
n > 100 cells). ns, not significant; ***p < 0.001 (Kruskal-Wallis test with Dunn’s
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Figure 4. DNA Damage Progression in Nbs1-del Cells
(A–C) hiMAC quantification of gH2AX and 53BP1 foci kinetics in G2 phase. Nbs1-del cells (6 dpo) were labeled with EdU for 1 hr, 3 hr, or 5 hr and stained with
gH2AX and 53BP1 antibodies, EdU, and DAPI.
(A) EdU-negative cells with 4N DNA were identified by hiMAC as cells remaining in G2 phase from the beginning of the EdU labeling.
(B and C) gH2AX and 53BP1 foci in G2 nuclei (B) were counted and the number of foci was plotted over time (C) (n > 100 cells). *p < 0.05; ***p < 0.001 (Kruskal-
Wallis test with Dunn’s test). Bars, 3 mm.
(D) Representative images (left) and quantification (right) of DNA bridges (arrow in the left panel) in anaphase of Nbs1-del (6 dpo) and control cells stained with
DAPI (n > 100 cells). ***p < 0.001 (chi-square test). Bars, 6 mm.
(E) Quantification of chromosome breaks from metaphase spreads of Nbs1-del (6 dpo) and control cells (n > 100 metaphases). Metaphases were stained by
telomere fluorescence in situ hybridization and DAPI. *p < 0.05 (Student’s t test).
(F) Representative images of Nbs1-del (5 dpo) and control G2 cells stained with gH2AX antibody and DAPI (left), and hiMAC quantification of MN in cells with or
without gH2AX foci in the main nucleus (right) (n = 3). ***p < 0.001 (one-way ANOVA with Tukey’s test). The arrow points to an MN. Bars, 3 mm.
(G) Representative images of Nbs1-del (indicated dpo) and control cells pulse labeled with EdU and stained with gH2AX and 53BP1 antibodies, EdU, and DAPI
(left). Bars, 3 mm.
(H) hiMAC quantification of gH2AX foci per nucleus noncolocalizing (white bars) or colocalizing (black bars) with 53BP1 foci from cells in (G). Colocalization of
gH2AX foci to 53BP1 foci and the total number of analyzed cells (N) are indicated. ns, not significant; ***p < 0.001 for comparison of total gH2AX foci (*) or gH2AX/
53BP1 double-positive foci (#) (Kruskal-Wallis test with Dunn’s test).
The error bars represent the SEM. See also Figure S6.
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Figure 5. Distinct Proliferation Arrests Precede Cell Death in Nbs1-del Cells
(A) Cell-cycle phase durations of control (EV) and Nbs1-inducible (CER) cell lines without 4-OHT or at 9 dpo as determined by the cumulative EdU labeling assay.
(B) hiMAC analysis of EdU-negative (proliferation arrested) Nbs1-del (9 dpo) and control cells with 2N (G0/G1) or 4N (G2) DNA content after 24 hr EdU labeling.
(C) Quantification of the gated areas in B (n = 3).
(D) Representative live-cell images of Nbs1-del (10–12 dpo) and control cells transfected with the FUCCI cell-cycle reporter system. Red and green fluorescence
indicates G1 and S/G2 phases, respectively. Cell-death events of Nbs1-del cells in G1, S/G2, and M phase are depicted. Numbers represent imaging time in
h:min. Bars, 25 mm.
(E) Quantification of cell-death events from cells in (D). The numbers represent the amount of cells that died during 48 hr in relation to all quantified cells. The
number of quantified cells from two independent experiments is indicated (N).
The error bars represent the SEM. See also Figure S7.for several cell cycles, although an increasing load of replica-
tion intermediates may convert to secondary DSBs, ultimately
leading to cell death.
In spite of intermediate conversion into DSBs, chromosome
bridges, and MN during the subsequent G2 and mitosis, Nbs1-
del cells can undergo several cell cycles without dying. Of partic-
ular importance are endogenous replication-induced DSBs,
which must be prevented by multiple mechanisms in S phase.
However, the S phase checkpoint is likely not a stable condition
and does not allow prolonged arrest. Therefore, the killing of cells
carrying DSBs in replication is a critical response to prevent the
accumulation of cells with genomic instability. However, we
found that the DSB level in Nbs1-del cells was stabilized during
cell-cycle progression (Figures 4G, 4H, and 6; dpo versus 5 dpo).
This damage equilibrium implies that DSBs per se do not kill
Nbs1-del cells, but arrest cell proliferation via DDR signaling
(see Figures 7B and 7C). Overriding proliferation arrest by p53
inactivation indeed caused extensive DNA damage, nuclear
fragmentation, and massive cell death (Figures 7F–7L). Consis-
tent with ATM-dependent DDR signaling and accumulative p53
activation in Nbs1-del cells (Zhang et al., 2012), increased levels
of phospho-p53 and -p21 were detectable at 6 dpo and 9 dpo,190 Cell Reports 6, 182–195, January 16, 2014 ª2014 The Authorsrespectively (Figure 7D). Similarly, we previously showed that
p53 overactivation impaired development of the cerebellum after
Nbs1 deletion in the mouse CNS (Frappart et al., 2005).
Together, these data suggest that continuous p53 activation
and p21 accumulation in Nbs1-del cells induce proliferation
arrest, which initially prevents cell death until the appearance
of gross genomic instability. The choice between proliferation
arrest and apoptosis has been attributed to the duration of p53
activation (Zhang et al., 2011). In this regard, our observation
suggests that persistent p53 activation may be the driving force
of apoptosis of Nbs1-del cells. Therefore, the death of Nbs1-del
cells is not due to acute replication stress or accumulated DSBs,
but is likely triggered by exceeding a critical threshold of contin-
uous antiproliferative or proapoptotic pressure in interphase, for
example, via p53 activation.EXPERIMENTAL PROCEDURES
Small Hairpin RNA Vector Construction
The construction of small hairpin RNA (shRNA) expression vectors was
performed as previously described (Zhou et al., 2010). Briefly, oligonucleotides
targeting the coding sequences and their complementary sequences were
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Figure 6. Replication Intermediates in Nbs1-del Cells Drive a Chk1-Dependent G2 Delay
(A) hiMAC quantification of theG2 population ofNbs1-del (6 dpo) and control cells treatedwith 60 nMMMC for 24 hr after 24 hr recovery, or 250 nMPARP inhibitor
AG014699 for 72 hr (n = 3). ns, not significant; *p < 0.05; **p < 0.01 (one-way ANOVA with Tukey’s test).
(B) Bottom: representative images of Nbs1-del (6 dpo) and control G2 cells untreated or treated with 250 nM PARP inhibitor (PARPi: AG014699) for 72 hr, pulse
labeled with EdU, and stained with gH2AX and 53BP1 antibodies, EdU, and DAPI. Top: hiMAC quantification of 53BP1 foci (n > 100 cells). ns, not significant;
***p < 0.001 (Mann-Whitney test). Bars, 5 mm.
(C) Toxicity assay of Nbs1-del and control cells after 4 days of treatment with PARPi (AG014699) at the indicated concentrations. Quantification of cells was
performed by high-content microscopy analysis of DAPI-stained nuclei (n = 3). *p < 0.05; **p < 0.01 (Student’s t test).
(D) Western blot analysis of Chk1 and Cdk1 phosphorylation in CER and EV cells at the indicated dpo. b-Tubulin was used as loading control. The level of Cdk1
phosphorylation was normalized to the total Cdk1 level.
(E and F) Analysis of G2 transition by cumulative EdU labeling.
(E) Representative images of mitotic Nbs1-del (6 dpo) and control cells preincubated for 2 hr with the indicated inhibitors (Chk1i: 250 nM UCN-01; Wee1i: 1 mM
MKK-1775), labeled with EdU for 4 hr, and stained with p-H3 (S28) antibody, EdU, and DAPI.
(F) The fraction of EdU-positive cells in the mitotic (p-H3 (S28)-positive) population was quantified by high-content analysis microscopy and plotted as ameasure
of the G2 transition (n = 3). ***p < 0.001 (one-way ANOVA with Tukey’s test). Bars, 5 mm.
The error bars represent the SEM. See also Figure S7.inserted into the vector under the control of the human U6 promoter with cyto-
megalovirus-driven enhanced GFP. All oligonucleotides contained the hairpin
loop sequence TTCAAGAGA. The targeting sequences were GGCTTGCCAG
CAACTTACA (shLuc) and GGTTAGAGCAGTGTGGCATAA (shRad51).
Cell Lines, Cell Culture, and Drug Treatments
InducibleNbs1 null (CER:Nbs1F/F;CreER+) and empty vector (EV) controlMEFs
(Nbs1F/F;CreER) were constructed from immortalized Nbs1F/F MEFs and
cultured as previously described (Yang et al., 2006). Reconstituted CER cells
were generated by overexpression of mouse Nbs1 cDNA. Primary in-
ducible Nbs1-null p53-null MEFs (Nbs1F/F;p53/;CreERT2+) and control
MEFs (Nbs1F/F;p53+/+;CreERT2+, Nbs1F/+;p53+/+;CreERT2+) were derived
from mouse embryos. To delete Nbs1, CER cells were cultured in medium
with 1 mM 4-OHT (Sigma-Aldrich) for 3 days. Control MEFs were CER cells
without 4-OHT treatment, unless otherwise indicated. For long-term or pulseClabeling of cells with EdU, cells were cultured in medium with 4 mM EdU
(Invitrogen) for 24 hr or 1 hr, respectively. Apoptosis was induced by 1 mM
MNNG (ABCR) for 30 min and analyzed after 24 hr recovery. APH (Sigma-
Aldrich) was used at 200 nM for 1–3 days. MMC (Sigma-Aldrich) was used at
60 nM for 24 hr and cells were analyzed after 24 hr of recovery. shRNA trans-
fection of MEF cells was performed with the Amaxa Cell Line Nucleofector
Kit R (Lonza). Nbs1 siRNA (D-009641-04; Thermo Scientific) and nontargeting
siRNA (D-001212-02; Thermo Scientific) were transfected using Lipofectamine
RNAiMAX (Invitrogen) together with Opti-MEM (GIBCO) according to the
manufacturer’s instructions. Details regarding the inhibitors usedaredescribed
in Supplemental Experimental Procedures.
Live-Cell Imaging
For live-cell imaging,Nbs1-del (9 dpo) and control MEFs were transfected with
the Fucci cell-cycle indicator system (FP-hCdt1(30/120) and FP-hGem(1/110);ell Reports 6, 182–195, January 16, 2014 ª2014 The Authors 191
025
50
75
100
A
0
25
50
75
100
%
 K
i6
7+
G
1 
ce
lls
0 1-2
Nbs1-delCtrl
> 2 γH2AX foci MN- +
Nbs1-delCtrl
**
***
ns *
***
%
 K
i6
7+
G
1 
ce
lls
B
all all
C
p53 pS15
p53
β-Actin
Nbs1
dpo 6-
EV
9 12 6- 9 12
CER
0.8 2.62.12.01.3 1.7
2.21.1 1.91.21.3 1.3
p21
0
20
40
60
80
100
%
 E
dU
+
ce
lls
Nbs1F/+ Nbs1F/F
+/+ +/+ -/- p53
***
ns
***
- 4-OHT
10 dpo
ns
Nbs1F/F
+/+ +/+ -/-p53
Nbs1F/+
-4
-O
H
T
10
 d
po
EdU DAPI
TUNEL DAPI
Nbs1F/F
+/+ +/+ -/-p53
Nbs1F/+
-4
-O
H
T
12
 d
po
Nbs1
p53
Fibrillarin
5-dpo 5-5-
0
2
4
6
8
10
**
ns
*
*
%
 T
U
N
E
L+
ce
lls
Nbs1F/+ Nbs1F/F
+/+ +/+ -/- p53
- 4-OHT
12 dpo
γH2AX EdU DAPI
Nbs1F/F
+/+ +/+ -/-p53
Nbs1F/+
-4
-O
H
T
10
 d
po
0
1
2
3
4
5
6
γH
2A
X
 fo
ci
 p
er
 
E
dU
-
nu
cl
eu
s
Nbs1F/+ Nbs1F/F
+/+ +/+ -/- p53
- 4-OHT
10 dpo
**
***
0
30
60
90
MN+
Fragmented
nuclei
Nbs1F/+ Nbs1F/F
+/+ +/+ -/- p53
- 10 dpo
%
 C
el
ls
- 10 - 10
N
bs
1-
de
l
C
trl
γH2AX
Ki67
DAPI
D
GFE
JIH
LK
***
Figure 7. p53-Dependent Proliferation Arrest in Nbs1-del Cells Restricts DNA Damage, Nuclear Fragmentation, and Cell Death
(A) Representative images of Nbs1-del (9 dpo) and control G1 cells pulse labeled with EdU and stained with gH2AX and Ki67 antibodies, EdU, and DAPI. G1 cells
were identified by hiMAC. Bars, 5 mm.
(B and C) G1 cells from (A) were grouped by number of gH2AX foci (B) andMN (C), and the percentage of proliferating (Ki67-positive) cells was quantified for each
group (n = 3). ns, not significant; *p < 0.05; **p < 0.01; ***p < 0.001 (one-way ANOVA with Tukey’s test).
(D)Western blot analysis of phosphorylated and total levels of p53 and its target p21 in CER and EV cells at the indicated dpo. b-Actin was used as loading control.
The levels of p53 phosphorylation and of p21 were normalized to the b-Actin level and are indicated at the bottom of the blot.
(E) Western blot analysis of total levels of p53 and Nbs1 in CreERT2+ primary MEFs of the indicated genotypes at the indicated dpo. Fibrillarin was used as loading
control.
(legend continued on next page)
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Lins et al., 2009) using the Amaxa Nucleofector Kit R (Lonza) and plated
directly to glass-bottomed dishes (ibidi). Imaging by spinning-disk confocal
microscopy (Zeiss) was started 18 hr after transfection and continued for at
least 48 hr, with an image acquisition interval of 10 min.
Western Blot Analysis
Western blotting was performed according to a previously published
protocol (Zhou et al., 2012). The antibodies used are listed in Supplemental
Experimental Procedures.
Subcellular Fractionation
Whole-cell extract (WCE) was prepared from pelleted cells. For isolation of
cytoplasmic and insoluble nuclear fractions, 3 3 106 cells were suspended
in buffer A (10 mM HEPES pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 340 mM
sucrose, 1 mM dithiothreitol [DTT], 0.5 mM Na3VO4, 2.5 mM sodium fluoride
[NaF], 1 mM phenylmethylsulfonyl fluoride [PMSF], 1 mM b-glycerolphos-
phate, 13 Complete Protease Inhibitor Cocktail (Roche), 10% glycerol). Triton
X-100 was added to a concentration of 0.1% and incubated for 5 min on ice.
Nuclei were pelleted (1,300 g, 4 min, 4C) and supernatant (S1) was cleared by
centrifugation (16,100 g, 10 min, 4C). The nuclei were lysed in buffer B (3 mM
EDTA, 0.2 mM EGTA, 1 mM DTT, 0.5 mM Na3VO4, 2.5 mM NaF, 1 mM PMSF,
1 mM b-glycerolphosphate, 13 Complete Protease Inhibitor Cocktail [Roche])
on ice for 10 min. Insoluble nuclear fraction (P2) was pelleted (1,700 g, 4 min,
4C) and washed in buffer B (10,000 g, 1 min, 4C). All fractions (WCE, S1, and
P2) were subjected to western blot analysis.
Immunocytochemistry
For immunocytochemistry, cells were fixed for 15 min at room temperature
(RT) in 3% PFA/0.025% glutaraldehyde/0.1% Triton X-100 or 4% paraformal-
dehyde (PFA)/0.1% Triton X-100 for RPA staining, and glutaraldehyde was
quenched with 0.1% NaBH4 in PBS for 10 min. The click reaction was per-
formed using the Click-iT EdU Alexa Fluor 647 Imaging Kit (C10340; Invitrogen)
for 1 hr. The TUNEL reaction was carried out using terminal deoxynucleotidyl
transferase (TdT; Fermentas). Cells were incubated with blocking solution (1%
BSA, 5% goat serum, 0.4% Triton X-100 in PBS) for 1 hr, with the primary anti-
body diluted in the blocking solution overnight at 4C (RPA antibody: 2 hr, RT),
and with fluorophore-conjugated secondary antibodies for 2 hr, and the nuclei
were stained with 1 mg/ml DAPI (D1306; Invitrogen) in PBS. Images of cells
were captured using a Pathway 435 Bioimager high-content analysis micro-
scope (Becton Dickinson). The antibodies used are listed in Supplemental
Experimental Procedures.
Fiber Assay
Cells were sequentially pulse labeled in growth medium with 25 mM CldU and
250mMIdU,washedwithcoldPBS,andcollectedbyscraping. Then, 1,000cells
were spread onto a microscope slide and lysed for 2 min in 7 ml lysis buffer
(200 mM Tris-HCl pH 7.4, 50 mM EDTA, 0.5% SDS). Chromatin was spread
by slide tiltingandfixed for 10min in 3:1methanol:acetic acid. Slideswere dried,
rehydrated, treated with 2.5 MHCl for 75min, washed, and incubated in block-
ingsolution (PBS,1%BSA,0.1%Tween-20) for 1hr. Fiberswere labeledwith rat
BrdU antibody (1 hr, 1:1000, ab6326; Abcam), fixed in 4% PFA for 10 min, and
sequentially labeledwithanti-rat AlexaFluor 555antibody (2 hr, 1:500;Molecular
Probes), mouse BrdU antibody (overnight at 4C, 1:1,500, 347583; BD), and(F) Representative images of CreERT2+ primary MEFs of indicated genotypes at t
Bars, 20 mm.
(G) High-content microscopy-based quantification of proliferative (EdU+) cells
independent experiments. ns, not significant; ***p < 0.001 (one-way ANOVA with
(H) Representative images of CreERT2+ primary MEFs of indicated genotypes at
EdU, and DAPI. Bars, 10 mm.
(I and J) Quantification of gH2AX foci in EdU nuclei (I) and frequency ofMN and nu
genotype and two independent experiments. **p < 0.01; ***p < 0.001 (one-way A
(K) Representative images of CreERT2+ primary MEFs of the indicated genotypes
(L) High-content microscopy-based quantification of TUNEL-positive cells fro
independent experiments. ns, not significant; *p < 0.05; **p < 0.01 (one-way ANO
The error bars represent the SEM.
Canti-mouse AlexaFluor 488 antibody (2 hr, 1:500; Molecular Probes). Slides
weremounted, imageswereacquiredwithan immunofluorescencemicroscope
(Imager.M1; Zeiss), and fiber lengths were measured with ImageJ software.
hiMAC Assay
Cells were pulse labeled with 4 mM EdU for 1 hr. Fixation, click reaction,
antibody and DAPI staining, and image acquisition were performed as
described above. Image sets were analyzed with CellProfiler 2.0 software
(Kamentsky et al., 2011) to identify nuclei, MN, and foci, and to measure signal
intensities. Cell-cycle scatterplots were generated from EdU signal (total
intensity = DNA synthesis) versus DAPI signal (total intensity = DNA content),
and G1 (2N, EdU), S (EdU+), and G2/M (4N, EdU) phases were gated.
S phase was further divided into early, mid, and late S phase on the basis of
DNA content. The DAPI mean signal, correlating with DNA condensation,
was further used to divide G2/M phase into early G2 (low condensation) and
late G2/M (high condensation) phase.
High-Content Microscopy Assays
The identification of G2 cells (4N DNA, EdU), which persisted in G2 phase
during 1–5 hr of EdU labeling, and quantification of foci in these cells were per-
formed by hiMAC. Cumulative EdU labeling was performed as previously
described (Gruber et al., 2011; Nowakowski et al., 1989). Briefly, cells were
labeled with 4 mM EdU for 1–28 hr and stained with click reaction, p-histone
H3 (S28) antibody, and DAPI as described above. The G2 length was calcu-
lated as the time at which 50% of mitotic (p-histone H3 [S28]-positive) cells
were EdU positive. The lengths of thewhole cell cycle and all remaining phases
were calculated as described previously (Gruber et al., 2011).
Toxicity Assay
Nbs1-del or control cells were cultured in 96-well dishes (190 cells/well) for
24 hr, followed by drug treatment for 24 hr. After 4 days, the cells were fixed
and the nuclei were stained with DAPI and counted by high-content micro-
scopy analysis (Cellomics Arrayscan VTI; Thermo Scientific). Survival was
calculated as the percentage of nuclei relative to wells without drug treatment.
Cytogenetic Analysis
For the visualization of chromosome breaks, we applied fluorescence in situ
hybridization using a telomere-specific PNA probe (SQ-PNAOL-11095;
Eurogentec) and prepared metaphase spreads as previously described
(Tong et al., 2001).
Flow Cytometry
For analysis of apoptosis by flow cytometry, cells were incubated with Annexin
V-FITC (1:100; BDPharMingen) in 100 ml binding buffer (10mMHEPES [pH7.4],
140mMNaCl, 2.5mMCaCl2) for 15minatRT. Then, 400ml of bindingbufferwith
0.2 mg/ml DAPI was added 15 min before analysis by flow cytometry using a
FACSCanto II (Becton Dickinson) and FACS Diva software (Becton Dickinson).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.celrep.2013.12.018.he indicated dpo, labeled with EdU for 24 hr, and stained with EdU and DAPI.
from (F) from at least two independent cell isolations per genotype and two
Tukey’s test).
the indicated dpo, pulse labeled with EdU, and stained with gH2AX antibody,
clear fragmentation (J) from (H) from at least two independent cell isolations per
NOVA with Tukey’s test).
at the indicated dpo stained with TUNEL and DAPI. Bars, 20 mm.
m (K), from at least two independent cell isolations per genotype and two
VA with Tukey’s test).
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